Dupilumab represents a breakthrough in the management of atopic dermatitis (AD), thanks to its powerful T-helper (Th)2-mediated immunity modulating activity. It can reduce the atopic skin molecular signature and induce a significant decrease in the clinical signs and symptoms of AD patients.

The emerging role of dupilumab in dermatological indications / Napolitano, Maddalena; Di Guida, Adriana; Nocerino, Mariateresa; Fabbrocini, Gabriella; Patruno, Cataldo. - In: EXPERT OPINION ON BIOLOGICAL THERAPY. - ISSN 1471-2598. - (2021), pp. 1-11-11. [10.1080/14712598.2021.1907341]

The emerging role of dupilumab in dermatological indications

Napolitano, Maddalena;Di Guida, Adriana;Nocerino, Mariateresa;Fabbrocini, Gabriella;Patruno, Cataldo
2021

Abstract

Dupilumab represents a breakthrough in the management of atopic dermatitis (AD), thanks to its powerful T-helper (Th)2-mediated immunity modulating activity. It can reduce the atopic skin molecular signature and induce a significant decrease in the clinical signs and symptoms of AD patients.
2021
The emerging role of dupilumab in dermatological indications / Napolitano, Maddalena; Di Guida, Adriana; Nocerino, Mariateresa; Fabbrocini, Gabriella; Patruno, Cataldo. - In: EXPERT OPINION ON BIOLOGICAL THERAPY. - ISSN 1471-2598. - (2021), pp. 1-11-11. [10.1080/14712598.2021.1907341]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/849716
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 9
social impact